Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review
Open Access
- 21 August 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in The Journal of Headache and Pain
- Vol. 14 (1), 72
- https://doi.org/10.1186/1129-2377-14-72
Abstract
Trigeminal neuralgia is a common disorder caused mainly by compression of the trigeminal nerve root by an overlying blood vessel. Pharmacotherapy and surgery are ineffective or unsuitable in many patients. Therefore, other therapeutic modalities have been tried, including injection of botulinum toxin type A (BTX-A). This study aims to systematically review the therapeutic efficacy and safety of BTX-A in trigeminal neuralgia. PubMed, EMBASE, Cochrane Library Clinical Trials and Web of Science from January 1966 to March 2013 were searched with the terms of “botulinum toxin” AND “trigeminal neuralgia”, and references of related articles were traced. Data on the efficacy and safety of BTX-A in this disorder were extracted and analyzed by at least 2 reviewers. Data for individual studies were reported, and pooled data were analyzed if appropriate. Five prospective studies and one double-blind, randomized, placebo-controlled study were identified. Response was achieved in approximately 70-100% of patients, and the mean pain intensity and frequency were reduced by approximately 60-100% at 4 weeks after treatment in most studies. Major adverse events were not reported. Available studies show BTX-A may be effective in treatment of trigeminal neuralgia. However, well-designed randomized, controlled, double-blinded trial is still lacking. Future BTX-A treatment studies on optimal dose, duration of the therapeutic efficacy, common AEs, and the time and indications for repeat injection would be promising.Keywords
This publication has 67 references indexed in Scilit:
- OnabotulinumtoxinA (BOTOX®)Drugs, 2012
- Topiramate versus Carbamazepine for the Treatment of Classical Trigeminal NeuralgiaCNS Drugs, 2011
- Secondary Trigeminal Neuralgia in Cerebellopontine Angle TumorsJournal of Neurological Surgery Part B: Skull Base, 2011
- Botulinum Toxin for Shoulder Pain: A Cochrane Systematic ReviewThe Journal of Rheumatology, 2011
- Incidence of facial pain in the general populationPain, 2009
- Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skinPain, 2009
- Clinical presentation of trigeminal neuralgia and the rationale of microvascular decompressionNeurological Sciences, 2008
- Anti-allodynic efficacy of botulinum neurotoxin A in a model of neuropathic painNeuroscience, 2007
- Ataxia and deafness in a young male: An unusual aetiologyNeurology India, 2006
- Headache and botulinum toxinThe Journal of Headache and Pain, 2005